Literature DB >> 17603714

Echocardiographic abnormalities in adolescent and adult Saudi patients with sickle cell disease.

Aamer Aleem1, Ahmed Jehangir, Mohammad Owais, Abdulkarim Al-Momen, Abdulrahman Al-Diab, Huda Abdulkarim, Hatem Alameri.   

Abstract

OBJECTIVE: Cardiovascular complications in sickle cell disease (SCD) have been well documented but cardiac involvement in Saudi patients with SCD is not known. We sought to identify cardiac abnormalities by echocardiography in adolescent and adult Saudi patients with stable SCD.
METHODS: Sixty-five consecutive patients with SCD followed at King Khalid University Hospital, Riyadh, were prospectively studied from January 2005 to December 2005. All patients underwent echocardiographic examination to determine chamber dimensions, left ventricular function, valvular anomalies and pulmonary artery pressure. Data were compared to normal age and gender-matched controls. Hematological data were also collected from the patients and correlated with the echocardiographic results.
RESULTS: Twenty-eight males and 37 females were evaluated. The mean age of the group was 24.5+/-9.2 (range 14-44) years. The most common abnormality found was pulmonary hypertension (PH) present in 25 (38%) patients. The majority of these patients had mild PH and only 6 (9%) patients had pulmonary artery systolic pressure (PASP) more than 40 mm Hg. Older age, lower level of fetal hemoglobin and high serum ferritin were associated with increased PASP. Other abnormalities present included dilated left atrium in 17 (26%) patients, dilated right atrium 13 (20%), dilated left ventricle 10 (15%), valvular anomalies 21 (32%) and reduced ejection fraction in 4 (6%) patients.
CONCLUSION: Cardiac abnormalities are found in a significant proportion of Saudi patients with SCD. Pulmonary hypertension is the most common finding while other abnormalities are less frequent.

Entities:  

Mesh:

Year:  2007        PMID: 17603714

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  7 in total

1.  Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.

Authors:  Mohammed Fakhry Abdul-Mohsen
Journal:  J Saudi Heart Assoc       Date:  2012-06-12

2.  Sickle cell disease with left ventricular non-compaction: A rare association.

Authors:  Prashanth Panduranga; Mohammed Al-Mukhaini
Journal:  J Cardiol Cases       Date:  2011-01-12

3.  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Authors:  Martin H Steinberg; William F McCarthy; Oswaldo Castro; Samir K Ballas; F Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; Myron A Waclawiw
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

4.  Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.

Authors:  Victor R Gordeuk; Andrew Campbell; Sohail Rana; Mehdi Nouraie; Xiaomei Niu; Caterina P Minniti; Craig Sable; Deepika Darbari; Niti Dham; Onyinye Onyekwere; Tatiana Ammosova; Sergei Nekhai; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

5.  Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia.

Authors:  Igoche D Peter; Mustafa O Asani; Shehu U Abdullahi; Ibrahim Aliyu; Stephen K Obaro; Fidelia Bode-Thomas
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-08-01       Impact factor: 2.184

6.  Left ventricular function and cardiac valvar annular dimensions among children with sickle cell anemia compared to those with hemoglobin AA type in Enugu, Nigeria.

Authors:  Josephat M Chinawa; Awore T Chinawa; Edmund N Ossai; Bartholomew F Chukwu; Ikenna K Ndu; Isaac N Asinobi
Journal:  Malawi Med J       Date:  2021-06       Impact factor: 0.875

7.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.

Authors:  Sarfraz Saleemi
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.